A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Clinical trial NCT07418749 · RECRUITING
Trial details
- NCT number
- NCT07418749
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-30
- Primary completion
- 2027-12-01
- Enrollment
- 398
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.